Reprint

Stroke, Dementia and Atrial Fibrillation

Edited by
September 2020
212 pages
  • ISBN978-3-03936-672-9 (Hardback)
  • ISBN978-3-03936-673-6 (PDF)

This book is a reprint of the Special Issue Stroke, Dementia and Atrial Fibrillation that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary
The present special issue will lead you to discover the association between cerebrovascular events, cognitive impairment and atrial fibrillation, through update reviews and original articles exploring the pathophysiological mechanisms underpinning this association and describing the latest results in term of stroke prevention in AF. An interesting scientific journey that reflects the recent advances in pharmacological treatments and interventional procedures involving both mind and heart.
Format
  • Hardback
License
© 2020 by the authors; CC BY licence
Keywords
memory loss; antioxidant; neuroprotective; acetylcholinesterase inhibitor; molecular docking; atrial; fibrillation; venous; thrombosis; anticoagulation; perception; chronic obstructive pulmonary disease; atrial fibrillation; cardiovascular risk; outcome; prognosis; novel oral anticoagulants; prosthetic valve replacement; atrial fibrillation; subclinical atrial fibrillation; stroke; ischemic cerebral events; catheter ablation; screening; cognitive impairment; atrial fibrillation ablation; stroke; iatrogenic interatrial septum defect; paradoxical embolism; anticoagulant interruption; atrial fibrillation; cardioversion; oral anticoagulation therapy; left atrial appendage thrombosis; transesophageal echocardiography; IL1B; IL1RN; polymorphism; stroke; inflammation; atrial fibrillation; cognitive decline; anticoagulation; rhythm control; microbleeds; cerebral ischemia; diabetes mellitus; atrial fibrillation; stroke; metformin; thiazolidinediones; GLP-1 receptor agonists; SGLT-2 inhibitors; subclinical atrial fibrillation; atrial high rate episodes; stroke; NOACs; non vitamin K oral anticoagulants; atrial fibrillation; stroke; oral anticoagulation; atrial fibrillation; anticoagulation; stroke; intracerebral hemorrhage; cerebral small vessel disease; brain MRI; circulating biomarkers; direct oral anticoagulants (DOACs); atrial fibrillation (AF); electrical cardioversion (EC); atrial fibrillation; surgical cryoablation; left atrial function; minimally invasive mitral valve repair; echocardiography; ischemic cerebral events; aneurysmal subarachnoid hemorrhage; outcome; interdisciplinary setting; atrial fibrillation; metabolic syndrome; obesity; cognitive impairment; dementia; n/a